Disease Activity Free Status
- 1 March 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 71 (3) , 269-270
Abstract
Opinion from JAMA Neurology — Disease Activity Free Status — A New End Point for a New Era in Multiple Sclerosis Clinical Research?Keywords
This publication has 4 references indexed in Scilit:
- Randomized study combining interferon and glatiramer acetate in multiple sclerosisAnnals of Neurology, 2013
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisArchives of Neurology, 2012
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysisThe Lancet Neurology, 2011
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009